Yarrow Bioscience, Inc.
YARW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566044
No open-market purchases or sales by Yarrow Bioscience, Inc. insiders were filed in the last 90 days; 46 institutions reported holding it in 13F filings for Q2 2026, worth $8.79M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Yarrow Bioscience, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −1 vs. Q4 2023
- Shares held
- 7.84M
- −64.4K (−0.8%) vs. Q4 2023
- Total value
- $22.9M
- +$4.50M (+24.4%) vs. Q4 2023
- New holders
- 5
- 8 more added
- Sold out
- 6
- 6 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YARW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $8.79M |
| Q1 2026 | 46 | $8.49M |
| Q4 2025 | 45 | $5.35M |
| Q3 2025 | 36 | $1.33M |
| Q2 2025 | 46 | $13.4M |
| Q1 2025 | 38 | $11.5M |
| Q4 2024 | 35 | $23.4M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 32 | $16.1M |
| Q1 2024 | 32 | $22.9M |
| Q4 2023 | 33 | $18.4M |
| Q3 2023 | 21 | $1.54M |
| Q2 2023 | 20 | $1.63M |
| Q1 2023 | 23 | $1.10M |
| Q4 2022 | 41 | $1.10M |
| Q3 2022 | 41 | $1.84M |
| Q2 2022 | 41 | $3.25M |
| Q1 2022 | 45 | $5.63M |
| Q4 2021 | 55 | $12.5M |
| Q3 2021 | 65 | $20.1M |
| Q2 2021 | 73 | $64.0M |
| Q1 2021 | 87 | $152.4M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Yarrow Bioscience, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cornerstone Planning Group LLC | 2 | $6 | 0.00% | +2 | New |
| UBS Group AG | 16 | $49 | 0.00% | −830−98.1% | Reduced |
| JPMorgan Chase & Co | 169 | $520 | 0.00% | +23+15.8% | Added |
| Wells Fargo & Company | 174 | $535 | 0.00% | +2+1.2% | Added |
| Russell Investments Group, Ltd. | 187 | $574 | 0.00% | 00.0% | Unchanged |
| MB, Levis & Associates, LLC | 1,041 | $3.20K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,241 | $3.81K | 0.00% | +451+57.1% | Added |
| Morgan Stanley | 1,868 | $5.74K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,187 | $6.71K | 0.00% | −598−21.5% | Reduced |
| Millennium Management LLC | 10,990 | $33.7K | 0.00% | −6,283−36.4% | Reduced |
| State Street Corp | 11,665 | $35.8K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 16,199 | $50.0K | 0.00% | +16,199 | New |
| Staley Capital Advisers Inc | 36,472 | $112.0K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 36,951 | $113.4K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 44,618 | $137.0K | 0.00% | −2,679−5.7% | Reduced |
| Susquehanna International Group, LLP | 60,323 | $185.2K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 69,633 | $213.8K | 0.00% | +20,051+40.4% | Added |
| Renaissance Technologies LLC | 80,576 | $247.0K | 0.00% | +34,200+73.7% | Added |
| Silverarc Capital Management, LLC | 86,383 | $265.2K | 0.07% | +86,383 | New |
| Prelude Capital Management, LLC | 94,600 | $290.4K | 0.02% | −23,500−19.9% | Reduced |
| Geode Capital Management, LLC | 106,775 | $327.8K | 0.00% | +12,432+13.2% | Added |
| ADAR1 Capital Management, LLC | 110,091 | $338.0K | 0.09% | +110,091 | New |
| Royal Bank of Canada | 175,372 | $538.0K | 0.00% | +174,107+13,763.4% | Added |
| Schonfeld Strategic Advisors LLC | 219,800 | $674.8K | 0.01% | +219,800 | New |
| Exome Asset Management LLC | 415,434 | $1.28M | 1.09% | +297,334+251.8% | Added |
| AlphaCentric Advisors LLC | 445,000 | $1.37M | 0.82% | −223,151−33.4% | Reduced |
| Palo Alto Investors LP | 445,434 | $1.37M | 0.15% | 00.0% | Unchanged |
| DSC Advisors, L.P. | 696,465 | $2.14M | 3.45% | 00.0% | Unchanged |
| Parkman Healthcare Partners LLC | 696,470 | $2.14M | 0.26% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 1,394,336 | $3.13M | 0.05% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,181,088 | $3.63M | 0.00% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,394,336 | $4.28M | 0.19% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −703,868−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −60,055−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,043−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −4,444−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Indiana Trust & Investment Management CO | 0 | $0 | 0.00% | −12−100.0% | Sold out |